Horn Kinney 4
4 · Olema Pharmaceuticals, Inc. · Filed Nov 12, 2021
Insider Transaction Report
Form 4
Horn Kinney
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2021-11-10$19.00/sh+22,417$425,923→ 29,458 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-11-10−5,251→ 162,791 totalExercise: $2.06Exp: 2030-06-09→ Common Stock (5,251 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-11-10−22,417→ 67,253 totalExercise: $19.00Exp: 2030-11-09→ Common Stock (22,417 underlying) - Exercise/Conversion
Common Stock
2021-11-10$2.06/sh+5,251$10,838→ 7,041 total - Sale
Common Stock
2021-11-10$26.88/sh−27,668$743,716→ 1,790 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- [F2]T he weighted average sale price for the transaction reported was $26.88, and the range of prices was between $26.56 and $27.32. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.
- [F4]One thirty-sixth of the remaining number of shares subject to the option vest on a monthly basis, subject to the Reporting Person's continuous service through each applicable vesting date.